FDA offers guidance on angioplasty and specialty catheters

By AuntMinnie.com staff writers

January 10, 2020 -- The U.S. Food and Drug Administration (FDA) has issued a draft guidance for premarket submission applications of peripheral percutaneous transluminal angioplasty (PTA) and specialty catheters.

The draft provides proposed recommendations for class II PTA balloon catheters and class II specialty catheters, including device labeling and modifications and nonclinical performance testing, such as bench and animal testing. Comments are being accepted on the draft guidance until March 13.


Copyright © 2020 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: